Thakur, Gitika
Dhanukate, Rutuja
Mou, Yongchao
Kunhiraman, Priya
Khadilkar, Archana
Srivastava, Siddharth
Alecu, Julian E.
Ebrahimi-Fakhari, Darius
Chen, Zhenyu
Blackstone, Craig
Li, Xue-Jun
Funding for this research was provided by:
Master of Science in Medical Biotechnology Program at the University of Illinois College of Medicine Rockford
Boston Children’s Hospital Translational Research Program
National Institute of Neurological Disorders and Stroke (K08NS123552)
Spastic Paraplegia Foundation
Massachusetts General Hospital
The Carter Foundation for Neurologic Research
National Institutes of Health (R01NS118066)
Article History
Received: 17 June 2025
Accepted: 22 September 2025
First Online: 17 November 2025
Declarations
:
: All experiments involving iPSCs have been approved by the Institutional Biosafety Committee of the University of Illinois. Skin punch biopsies were obtained following a clinical research procedure (protocols #IRB-P00016199, #IRB-P00033016) authorized by the Institutional Review Board at Boston Children’s Hospital.
: Not applicable.
: The authors declare that they have no competing financial interests.